Pearla Awad: Liposomal Iron Is Better Tolerated, With Fewer Adverse Effects and Lower Constipation Rates
Pearla Awad, Student Council, Cardiology Society Research Officer at RCSI Medical University of Bahrain, shared on LinkedIn about a recent article she and her colleagues co-authored, published in European Journal of Pediatrics, adding:
”Proud to share our latest publication in the European Journal of Pediatrics:
‘Safety and efficacy of liposomal iron for iron deficiency anemia in pediatric population: a systematic review and meta-analysis of randomized controlled trials.’
In this study, we analyzed data from four randomized controlled trials involving 454 pediatric patients.
We found that liposomal iron is better tolerated, with fewer adverse effects and lower rates of constipation, while delivering comparable, and in some cases greater, hematologic outcomes compared to conventional oral iron.
Have a read.
This project was a great opportunity to explore an evolving therapeutic approach in pediatric hematology and contribute to the growing evidence supporting liposomal iron formulations. Grateful to all co-authors and collaborators for their contributions and teamwork throughout this project.”
Title: Safety and efficacy of liposomal iron for iron deficiency anemia in pediatric population: A systematic review and meta-analysis of randomized controlled trials
Authors: Abdullah M. Alharran, Esraa Yousef Almutairi, Waleed Bader Alazemi, Fatemah Adel Alnejadah, Hasan S Hasan, Layal AlOufan, Asayel M Alsultan, Hala AlOmar, Maryam Alqayem, Joy Maasarani, Aljazi Alohaly, Pearla Awad, Abdullatif Alfehaid
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 4, 2026, 18:57Connecting Haemophilia Centres, Certifying Treaters, and Improving National Data in Romania – EHC
-
Nov 4, 2026, 18:45Smitirupa Mishra: A Practical Guide to Coagulation Pathway Assessment and Laboratory Interpretation
-
Nov 4, 2026, 15:59Alessandra Bosch: A Successful Patient Day for the Bleeding Disorders Community in Zürich
-
Nov 4, 2026, 15:47Wolfgang Miesbach: Targeting Hepatic Endothelial Cells for Lentiviral Gene Therapy in Haemophilia A
-
Nov 4, 2026, 15:20Augustina Isioma Ikusemoro: Before You Transfuse, Think PBM
-
Nov 4, 2026, 14:23Advancing Hemophilia Care Through Global Research – WFH
-
Nov 4, 2026, 14:12Jean-Jacques Kiladjian: From JAK Inhibitor-Associated Skin Cancers to Laboratory Discovery
-
Nov 4, 2026, 13:59Rita Li: ASH 2026 Abstract Achievement Award for Gut Microbiome Research
-
Nov 4, 2026, 13:38Omid Seidizadeh: Improving Access to von Willebrand Disease Diagnosis and Treatment Across Europe